We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Device Risk, Benefit Analysis Clarified in Agency Guidance
Device Risk, Benefit Analysis Clarified in Agency Guidance
September 1, 2011
Sponsors can find insights into how reviewers analyze device risks and benefits in a new FDA draft guidance.